Background: Tissue thickness at the site of ablation is a determinant of lesion transmurality. We reported the feasibility, safety, and efficacy of longstanding persistent atrial fibrillation ablation, incorporating deliberate left atrial appendage (LAA) isolation and occlusion, and identified systematic differences in ostial LAA tissue thickness in a matched cohort of cadaveric specimens.
INTRODUCTION
Catheter ablation is an effective treatment for symptomatic drug refractory paroxysmal and persistent atrial fibrillation (PsAF) and in certain circumstances may be offered as a first-line treatment. 1 Preablation imaging is increasingly used; however, attempts to validate imaging results using direct comparison with tissue measurements have rarely been made. One reason for AF recurrence is a failure to achieve durable isolation of regions targeted at the time of intervention, which may be related to tissue thickness at the ablation site.
The feasibility, safety, and efficacy of longstanding PsAF ablation, incorporating deliberate left atrial appendage (LAA) isolation and occlusion has recently been demonstrated. 2, 3 In this study, we assessed atrial wall thickness from preprocedural cardiac computed tomography (CCT) and compared it with direct measurement of wall thickness from a matched sample of cadaveric specimens. Using these wall thickness measurements, we investigated whether LAA tissue thickness contributed to acute electrical reconnection of the LAA following its ostial isolation by radiofrequency (RF) ablation.
METHODS

Clinical
The research study protocol was approved by the regional ethics committee and conformed to the Declaration of Helsinki. This study enrolled 22 patients with longstanding PsAF planned for ablation. All procedures were performed after obtaining written informed consent. Prior to ablation patients underwent contrast-enhanced CCT to assess LAA anatomy and exclude thrombus. Patients subsequently underwent wide-area circumferential pulmonary vein isolation and linear ablation at the left atrial roof, lateral mitral valve (MV) isthmus, and cavotricuspid isthmus under general anesthetic following transesophageal echocardiography. LAA electrical isolation was also performed with ablation confined to the atrial side of the LAA ostium.
In addition, ablation was performed at the left superior pulmonary vein (LSPV)-LAA ridge on both the pulmonary venous and LAA sides. Following electrical isolation, confirmed by demonstration of entrance and exit block using a circumferential mapping catheter within the LAA, a 60-minute waiting period was observed following which electrical isolation was reassessed with adenosine provocation. In the case of left atrium (LA)-to-LAA reconnection, the site of conduction recovery was defined according to the earliest electrogram observed on the circumferential mapping catheter and further ablation performed until it was reisolated. Following completion of ablation, the LAA was occluded using a Watchman percutaneous occlusion device.
CCT
All patients were scanned using a Siemens Somatom Definition Flash Dual Source CT (Siemens, Forchheim, Germany). A high-pitch helical prospective acquisition was performed starting 1 cm above the carina and extending to the apex of the heart. Acquisition started from approximately 60% of the R-R interval and continued until the end of the scan length, with breath held in expiration. The standard scan was performed using a test bolus technique for scan timing. A delayed scan was performed 60 seconds following the beginning of the standard scan to allow contrast equilibration within the blood pool and involved a further acquisition from 1 cm above carina and extending 40 mm to cover the LAA. Exposure parameters were adjusted according to patient size. Scans were performed at 80 kV and 400 quality referenced mAs (body mass index [BMI] < 20 kg/m 2 ), 100 kV (300 mAs), or 120 kV (200 mAs) (BMI > 30kg/m 2 ). Images were reconstructed using filtered back-projection at 0.75-mm slice width and 0.5-mm slice increment. A total of 95 mL of contrast was administered at 5-6 mL/s for 20 g/18 g cannula, respectively, and according to the following protocol: 15 mL contrast (test bolus; 5-6 mL/s); 40 mL saline (5-6 mL/s); pause; 50 mL contrast (5-6 mL/s); 50 mL contrast and saline (mixed at a ratio of 1:1; 5-6 mL/s); 25 mL saline (5 mL/s). The overall median (range) radiation dose for this protocol is 3.5 mSv (2.1-5.2 mSv), with a dose-length product of 251 mGycm (150-374 mGycm).
CCT analysis
All CCT analysis was performed by a single reader blinded to the electrophysiology procedural data. Using a previously validated technique, 4 CCT scans were processed to generate three-dimensional maps of tissue thickness across the LA. The process generated a segmentation of the atrial wall, which was then processed to calculate wall thickness (see Figure 1 and Supplementary Data). The segmentation of the atrial wall was reviewed to identify areas with potential errors (see 
Histology
Ten ex vivo human hearts were assessed from patients matched for the duration of continuous AF and left atrial size. No ablation had been performed in these patients. As previously reported, tissue thickness at the LAA ostium was assessed. 2 Briefly, the hearts were incised laterally through the LA and ventricle to expose the LAA ostium. The tissue was divided into blocks corresponding to four quadrants (superior, inferior, anterior, and posterior) ( Figure 3E 
Statistics
All statistical calculations were carried out in SPSS Statistics (IBM Corporation, Armonk, NY, USA). Continuous variables are expressed as mean ± standard deviation. Means were compared using one-way analysis of variance (ANOVA) or two-tailed, independent samples student's t-test. A result was considered statistically significant at the 5% significance level (P < 0.05).
RESULTS
Clinical
Detailed outcome data and follow-up for the study cohort has previously been reported. 2 The focus of this report is the regional distribution of acute LAA electrical reconnection following electrical isolation and its relation to ostial LAA tissue thickness. Of the 22 patients enrolled, acute electrical isolation was achieved in 20 patients (91%).
Acute electrical reconnection of the LAA occurred in 17 of these 20 patients. In each case, reconnection occurred spontaneously during the waiting period. Thirty-seven episodes of acute electrical reconnection occurred in a total of 21 individual quadrants (2.2 ± 1.2 per case).
These occurred in the anterior quadrant in 21 cases (57%), superior quadrant in 13 cases (35%), inferior quadrant in two cases (5%), and posterior quadrant in one case (3%). In two cases, successful LAA isolation was never achieved. The average RF time to achieve complete LAA isolation (including the ablation of any acute reconnection(s) after initial LAA isolation) was 33.5 ± 27.7 minutes and was performed using a continuous ("drag") ablation technique.
CCT
Mean wall thickness of each section (posterior, inferior, anterior, and superior) of the base of the LAA was calculated from each CCT 
Histology
As previously reported, 2 in the 10 human hearts that were examined from patients matched to the study population according to duration of AF and LA diameter, tissue in the anterior (2.5 ± 0.8 mm, range 1.4-4.0 mm) and superior (2.4 ± 1.2 mm, range 1.1-4.8 mm) quadrants was significantly thicker than the inferior (1.6 ± 0.8 mm, range 0.6-3.6 mm) and posterior 1.6 ± 0.8 mm, range 0.8-2.9 mm) quadrants.
Lesion efficacy and wall thickness
In patients in whom complete LAA isolation was achieved, 74 quad- Some regions demonstrated multiple episodes of electrical reconnection and required repeated RF delivery to achieve durable electrical isolation. We considered whether tissue thickness was a factor in the likelihood of recurrent reconnection. One-way ANOVA demonstrated a significant difference (P = 0.032) between the mean wall thicknesses for areas with 0 (mean thickness = 1.5 ± 0.5 mm, n = 57), 1 (mean thickness = 1.9 ± 0.7 mm, n = 11), and > 1 (mean thickness = 2.0 ± 0.5 mm, n = 7) acute reconnections. Tissue thickness was significantly lower in segments with 0 versus 1 acute reconnection (P = 0.048) and segments with 0 versus > 1 (P = 0.036) while there was no significant difference between segments with 1 versus > 1 acute reconnections (P = 0.80).
DISCUSSION
The major findings of this study are: (1) regional atrial wall thickness can be measured using CCT in humans; (2) differences in circumferential ostial LAA tissue thickness correspond with observations in AFmatched cadaveric samples, and (3) local tissue thickness may influence effectiveness of catheter ablation during LAA isolation.
CCT is the optimal modality for assessing atrial wall thickness due to its high spatial resolution and clear identification of the endocardial surface. It is the most widely used modality for this indication, 5 but validation of CCT results against direct tissue measurements has been limited. Our study is the first to compare in vivo, CCTderived wall thickness measurements at specific atrial locations with human tissue measurements from a matched cadaveric cohort. Previous studies have demonstrated significant variation in wall thickness at different atrial locations. [6] [7] [8] We have previously demonstrated that tissue thickness is different at each of the four quadrants of the LA-LAA junction on pathological samples. 2 The identification of greater wall thickness in the anterior and superior segments of the LA-LAA junction on CCT imaging is consistent with results from direct tissue examination.
The absolute value of tissue thickness derived from CCT in this study is similar to those taken from the cadaveric cohort; however, caution should be used when directly comparing these measurements. CCT represents a robust approach to assessing thickness in threedimensional space. 9 This strategy, while optimal for in vivo imaging, could not be taken for the tissue samples, in which a simple Euclidean distance in a single tissue plane was taken. These differences in tissue loading at the time of measurement, measurement methodology, and patient groups mean the results are best interpreted as confirmation that regional differences in tissue thickness exist in vivo throughout the atrium and that these may be satisfactorily detected using CT imaging.
Tissue thickness has previously been reported as a predictor of atrial ablation success. 10 Under the hypothesis that transmural lesions may be more difficult to create in thicker tissue, we considered tissue thickness in regions with and without durable electrical isolation.
We have demonstrated that tissue was thinner at locations where there was no recovery of electrical conduction following initial RF delivery (1.6 mm) than those at which there was recovery (1.9 mm).
The results presented here demonstrate for the first time a relationship between local atrial tissue thickness and a defined electrical end point. Acute electrical isolation is an important endpoint in most clinical ablation strategies and considered an important determinant of long-term lesion durability. 11 The magnitude of difference in thickness between quadrants may be unlikely to be relevant to achieving a transmural lesion. However, an average thickness was calculated across the quadrant in order to confidently include the point of electrical reconnection. This averaging is likely to result in reduced absolute differences between calculated tissue thickness than if point measurements at the point of electrical reconnection were taken. Power, temperature, and contact force are routinely used to titrate RF delivery in order to improve the durability of atrial ablation. [11] [12] [13] The accurate titration of RF delivery may be further facilitated by software tools that aggregate information from known determinants of lesion morphology into simple scales. 14, 15 These tools offer the prospect of further refinement in the titration of RF based on multiple parameters computed in real time. The use of such tools has previously depended largely on the assumption of a uniform tissue thickness. The evidence presented here, and emerging from other centers, 16 is that this assumption is not valid. In the future, tools to predict atrial lesion adequacy may facilitate titrated RF delivery based on local tissue thickness as well as ablation parameters. Importantly, from a safety per- 
LIMITATIONS
The acquired CCT resolution did not adequately identify the boundary between LAA epicardium and LSPV in a proportion of CCTs. Affected CCTs were readily identifiable from the volume-rendered segmentation of the atrial wall (Figure 6 ), so this is unlikely to result in spurious measurements; however, in these CCTs accurate prediction of tissue thickness was not possible. Better soft tissue contrast and higher resolution CCT may reduce the incidence of this issue in the future. 17 Using the current imaging and segmentation strategy, this technique for assessing local wall thickness can only be comprehensively applied in cases where adequate definition between the wall of the LAA and the LSPV exists.
In addition, the strategy for measuring wall thickness was different on CCT and pathological samples and the cohorts were different.
This was not a controlled study of the effect of tissue thickness on success of atrial ablation and there were differences in RF energy delivery at different sites. This means that no conclusions can be drawn about the titration of RF energy on the basis of tissue thickness. In addition, while there was a clear histological definition of the LA-LAA junction, this narrow portion of tissue was not identified on EAMS. While the RF was likely to have been delivered in the vicinity of this portion of tissue it may not have been localized precisely here in all cases.
Additional factors will also influence likelihood of achieving acute electrical isolation including energy delivery, catheter stability, and orientation. The thickest tissue was found in the anterior quadrant of the LAA ostium, which is also typically the most difficult position in which to achieve catheter stability and this may be an additional factor influencing likelihood of achieving acute electrical isolation. 
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